Follow-The-Filings

Security

Definium Therapeutics Inc. · COM SHS

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 7 new max 0.0% (Dmitry Balyasny - Balyasn...)

owners 8
max % 0.0%
tracked value $98M
qoq N 7 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 1,274,221 $24M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce -0.01 pp 1,200,825 $23M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% New 0.0% 846,896 $16M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% New 0.0% 1,333,442 $25M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% New 0.0% 271,717 $5M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% New 0.0% 175,490 $3M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% New 0.0% 57,094 $1M hist
Ancora Advisors LLC 2026 Q1 0.0% New 0.0% 251 $5 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$95.73M -$108.68M -$183.79M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $103.87M $281.62M $419.32M
Total non-current assets * $20.67M $20.53M $20.78M
Total assets $124.54M $302.15M $440.1M
Total current liabilities $32.25M $38.85M $66.7M
Total non-current liabilities * $14.16M $21.85M $41.08M
Total equity $78.13M $241.45M $332.33M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$64.36M -$79.13M -$131.56M
Cash from investing -$151.61M
Cash from financing $21.85M $253.2M $267.27M
Net change in cash -$42.44M $174.04M -$15.9M

ownership over time

filing count by report period · click a bar for that quarter’s holders

period archive